Biomedical Research Assoc Inc is categorized under Medical Research in Akron, OH and active since 2000.
Biomedical Research Assoc Inc was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5416111 by the NAICS.
If you are seeking more information, feel free to contact Michelle Evancho-Chapma, Marketing at the company’s single location by writing to 526 South Main St # 801f, Akron, Ohio OH 44311 or by phoning (330) 730-3331. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biomedical Research Assoc Inc |
| Contact Person: | Michelle Evancho-Chapma, Marketing |
| Address: | 526 South Main St # 801f, Akron, Ohio 44311 |
| Phone Number: | (330) 730-3331 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5416111 |
| Share This Business: |
Biomedical Research Assoc Inc was started in 2000 to provide professional Medical Research under the SIC code 8733 and NAICS code 5416111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michelle Evancho-Chapma, Marketing for inquiries that concern Biomedical Research Assoc Inc by calling the company number (330) 730-3331, as your correspondence is most welcome. Additionally, the physical location of the single location of Biomedical Research Assoc Inc can be found at the coordinates 41.07167,-81.52553 as well as the street address 526 South Main St # 801f in Akron, Ohio 44311.
For its online presence, you may visit Biomedical Research Assoc Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.